Ventyx Biosciences Ownership | Who Owns Ventyx Biosciences?


OverviewForecastFinancialsChart

Ventyx Biosciences Ownership Summary


Ventyx Biosciences is owned by 62.40% institutional investors, 4.11% insiders, and 33.49% retail investors. Point72 asset management is the largest institutional shareholder, holding 8.28% of VTYX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.43% of its assets in Ventyx Biosciences shares.

VTYX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVentyx Biosciences62.40%4.11%33.49%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Point72 asset management5.90M8.28%$12.62M
Blackrock4.77M7.72%$11.02M
Affinity asset advisors4.54M6.37%$9.71M
Ubs group3.78M5.35%$8.28M
Vanguard group3.51M4.96%$7.68M
Tang capital management3.10M4.35%$6.63M
Marshall wace, llp2.40M3.37%$5.13M
Vestal point capital, lp2.00M2.81%$4.28M
Goldman sachs group1.51M2.14%$3.31M
Geode capital management1.41M2.00%$3.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Qiming u.s. ventures management412.23K1.77%$902.77K
Affinity asset advisors4.54M1.33%$9.71M
Sectoral asset management931.62K1.32%$1.99M
Sio capital management1.31M1.07%$2.80M
Ikarian capital967.59K0.40%$2.07M
Tang capital management3.10M0.34%$6.63M
Monaco asset management sam761.89K0.29%$1.63M
Sphera funds management555.81K0.28%$1.19M
Redmile group1.11M0.25%$2.39M
Vestal point capital, lp2.00M0.23%$4.28M

Top Buyers

HolderShares% AssetsChange
Affinity asset advisors4.54M1.33%4.54M
Ubs group3.78M0.00%2.59M
Marshall wace, llp2.40M0.01%2.40M
Point72 asset management5.90M0.02%1.66M
Blackrock4.77M0.00%1.02M

Top Sellers

HolderShares% AssetsChange
Capital investors---5.25M
Farallon capital management---3.17M
Blackrock funding, inc. /de1.37M0.00%-3.07M
Cormorant asset management, lp---2.71M
Octagon capital advisors lp---2.39M

New Positions

HolderShares% AssetsChangeValue
Affinity asset advisors4.54M1.33%4.54M$9.71M
Marshall wace, llp2.40M0.01%2.40M$5.13M
Sectoral asset management931.62K1.32%931.62K$1.99M
Jacobs levy equity management475.73K0.00%475.73K$1.10M
Susquehanna portfolio strategies159.60K0.01%159.60K$341.54K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Zurcher kantonalbank (zurich cantonalbank)-55.00
Avion wealth-63.00
Federation des caisses desjardins du quebec-120.00
Modus advisors-150.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025116-3.33%44,424,8000.02%621.60%609.09%4014.29%
Mar 31, 20259-92.91%8,136,748-85.06%110.19%4-94.20%3-89.66%
Dec 31, 20241211.68%53,151,2081.28%751.36%658.33%28-9.68%
Sep 30, 2024119-52,481,496-7.84%741.14%607.14%31-16.22%
Jun 30, 2024118-9.23%56,948,301-3.20%920.93%56-26.32%36-5.26%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A5.25M7.43%2.89M
Vanguard Total Stock Mkt Idx Inv1.99M2.79%211.60K
Vanguard Institutional Extnd Mkt Idx Tr647.55K0.91%-225.46K
Fidelity Small Cap Index621.71K0.87%-23.02K
iShares Russell 2000 Value ETF536.88K0.75%-
Delaware Healthcare I430.00K0.61%-
Macquarie Healthcare I430.00K0.60%-
State St Russell Sm/Mid Cp® Indx NL Cl C419.68K0.59%-
State St Russell Sm/Mid Cp® Indx SL Cl I419.68K0.59%-
iShares Biotechnology ETF365.42K0.52%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 02, 2025Nuss John CHIEF SCIENTIFIC OFFICERSell$2.02K
Dec 27, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$49.84K
Dec 23, 2024Gujrathi Sheila-Buy$300.57K
Dec 19, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$29.68K
Nov 25, 2024Mohan Raju CEO AND PRESIDENTBuy$524.94K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1--
2024 Q432
2024 Q3--
2024 Q2-4

VTYX Ownership FAQ


Who Owns Ventyx Biosciences?

Ventyx Biosciences shareholders are primarily institutional investors at 62.40%, followed by 4.11% insiders and 33.49% retail investors. The average institutional ownership in Ventyx Biosciences's industry, Biotech Stocks , is 306.59%, which Ventyx Biosciences falls below.

Who owns the most shares of Ventyx Biosciences?

Ventyx Biosciences’s largest shareholders are Point72 asset management (5.9M shares, 8.28%), Blackrock (4.77M shares, 7.72%), and Affinity asset advisors (4.54M shares, 6.37%). Together, they hold 22.37% of Ventyx Biosciences’s total shares outstanding.

Does Blackrock own Ventyx Biosciences?

Yes, BlackRock owns 7.72% of Ventyx Biosciences, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.02M$. In the last quarter, BlackRock increased its holdings by 1.02M shares, a 27.34% change.

Who is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested, with 1.77% of its assets in 412.22K Ventyx Biosciences shares, valued at 902.77K$.

Who is the top mutual fund holder of Ventyx Biosciences shares?

American Funds SMALLCAP World A is the top mutual fund holder of Ventyx Biosciences shares, with 7.43% of its total shares outstanding invested in 5.25M Ventyx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools